"Située dans le quartier des Arènes, en centre-ville et à proximité des entrées de la rocade, la clinique Ambroise Paré du groupe ELSAN est un établissement qui confirme sa position par son offre de soins complète dans le paysage Toulousain. L’établissement propose une prise en charge des plus globales à travers son activité dans de nombreux domaines de l'exercice médicale (urgences adultes, médecine, chirurgie, maternité et néonatalogie, dentaire, imagerie et laboratoire de biologie, kinésithérapie…) , ses équipements et son organisation."

During the past decade, Clinique Ambroise Pare conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Ambroise Pare" #1 sponsor was "Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète" with 1 trials, followed by "Coloplast A/S" with 1 trials sponsored, "Elsan" with 1 trials sponsored, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials sponsored and "Janssen Scientific Affairs, LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Ambroise Pare" #1 collaborator was "Medtronic France SAS" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Ambroise Pare" are "Crohn Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Diabetes" (1 trials), "Inflammatory Bowel Diseases" (1 trials) and "Over Active Bladder" (1 trials). Many other conditions were trialed in "Clinique Ambroise Pare" in a lesser frequency.

Most popular intervention types in "Clinique Ambroise Pare" are "Device" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (40 mg)" (1 trials), "Altis Single Incision Sling" (1 trials), "DIABEO software" (1 trials), "Medical and neuropsychological assessments" (1 trials) and "Placebo for Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Ambroise Pare" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Ambroise Pare". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clinique Ambroise Pare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Ambroise Pare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".